You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Xpert Xpress SARS-CoV-2 Test

News Releases

Cepheid Schedules 2011 Fourth Quarter and Full Year Financial Results Announcement and Webcast

SUNNYVALE, Calif., Jan. 11, 2012 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2011 fourth quarter and full year ended December 31, 2011, on Thursday, January 26, 2012, after the close of the market.

The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, January 26, 2012, to discuss the results.  To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.

Interested participants and investors may also listen to the live teleconference call by dialing (866) 713-8395 or (617) 597-5309, and entering participant code 42214013.  A replay will be available for seven days beginning at 4 p.m. Pacific Time.  Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 57636855.

About Cepheid

Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.  By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.  Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

CONTACTS:

 

For Media Inquiries:

For Investor Inquiries:

 

 

Jared Tipton

Cepheid Corporate Communications

Tel: (408) 400 8377

communications@cepheid.com

 

Jacquie Ross

Cepheid Investor Relations

Tel: (408) 400 8329
investor.relations@cepheid.com

 

 

SOURCE Cepheid

Back to Top